1F6.F FERMENTALG EO -04

Healthcare Biotechnology Frankfurt Exchange
0.3785 EUR
Close of Nov 11, 2026
0.3490 0.6290
Market cap
EUR 45.4M
P/E
-
P/B
1.46x
ROE
-37.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 1F6.F undervalued?

Graham number

The Graham number of FERMENTALG EO -04 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

FERMENTALG EO -04 fundamental analysis

No fundamental analysis for FERMENTALG EO -04 yet.

FERMENTALG EO -04 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About FERMENTALG EO -04

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 20…

Full company profile